V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220020571 | 220006710 | 1.55 | 45 | Disease modification (D) | 2016-08-12 | 2017-03-25 | Cytarabine Low Dose | N | null | 220025773 | CYTARABINE |
| 220020572 | 220006717 | 0 | 81 | Curative (C) | 2016-11-25 | 2016-12-27 | CYTARABINE | 02 | N | 220025802 | CYTARABINE |
| 220020575 | 220006728 | null | null | Curative (C) | 2014-06-27 | 2014-12-08 | AML MyeChild 01 A Mitozantrone/Cytarabine | N | null | 220025841 | NOT MATCHED |
| 220020576 | 220006731 | 1.55 | 72 | Palliative (P) | 2017-07-23 | 2017-08-02 | Cytarabine Low Dose | N | N | 220025844 | CYTARABINE |
| 220020577 | 220021472 | null | 9.9 | Disease modification (D) | 2016-06-18 | 2016-11-18 | null | N | null | 220025943 | NOT MATCHED |
| 220020578 | 220022342 | null | 0 | Palliative (P) | 2015-10-04 | 2015-10-05 | Hydroxycarbamide | N | N | 220025945 | HYDROXYCARBAMIDE |
| 220020579 | 220006749 | null | 0 | Curative (C) | null | 2017-12-28 | Hydroxycarbamide | 2 | N | 220025947 | HYDROXYCARBAMIDE |
| 220020580 | 220006754 | 0 | 35 | Curative (C) | 2014-05-29 | 2014-09-18 | EZ | 02 | N | 220025965 | NOT MATCHED |
| 220020581 | 220006758 | 1.78 | 0 | Palliative (P) | null | 2015-02-12 | Hydroxycarbamide | N | null | 220025977 | HYDROXYCARBAMIDE |
| 220020582 | 220013725 | 0 | 0 | Palliative (P) | 2015-06-26 | 2015-12-14 | Hydroxycarbamide | N | N | 220025983 | HYDROXYCARBAMIDE |
| 220020583 | 220006763 | null | 85.6 | Disease modification (D) | 2016-07-07 | 2016-11-21 | Hydroxycarbamide | N | null | 220025993 | HYDROXYCARBAMIDE |
| 220020584 | 220006774 | null | 96.7 | null | 2013-10-17 | 2013-10-21 | CYTARABINE | N | null | 220026046 | CYTARABINE |
| 220020585 | 220006776 | 0 | 12.1 | Disease modification (D) | 2014-01-08 | 2014-01-08 | null | 02 | N | 220026051 | NOT MATCHED |
| 220020587 | 220013742 | 1.7 | null | null | 2017-10-25 | 2017-11-26 | Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE | null | null | 220026091 | NOT MATCHED |
| 220020588 | 220013745 | 1.66 | 87.2 | Palliative (P) | 2016-06-13 | 2016-06-13 | Hydroxycarbamide | N | N | 220026122 | HYDROXYCARBAMIDE |
| 220020589 | 220013746 | null | 85.6 | Palliative (P) | 2019-03-28 | 2019-03-29 | Hydroxycarbamide | N | N | 220026127 | HYDROXYCARBAMIDE |
| 220020590 | 220006796 | null | 0 | Curative (C) | 2017-06-26 | 2017-06-26 | APML Relapse Consolidation | N | N | 220026128 | NOT MATCHED |
| 220020591 | 220006805 | 0 | 11.6 | Curative (C) | 2014-12-31 | 2015-01-02 | AML MyeChild 01 Triple IT | 2 | N | 220026157 | NOT MATCHED |
| 220020592 | 220006813 | null | 12.1 | Curative (C) | 2017-01-27 | 2017-01-31 | null | N | N | 220026178 | NOT MATCHED |
| 220020593 | 220017496 | 1.75 | 98 | Curative (C) | 2016-03-07 | 2016-03-18 | ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYCLOPHOSPHAMIDE | null | N | 220026183 | NOT MATCHED |
| 220020594 | 220006819 | 1.91 | null | Palliative (P) | 2019-06-09 | 2019-06-09 | Hydroxycarbamide | N | N | 220026210 | HYDROXYCARBAMIDE |
| 220020595 | 220006833 | 1.8 | null | Curative (C) | 2015-11-16 | 2016-02-11 | AML MyeChild 01 FLA | N | N | 220026249 | NOT MATCHED |
| 220020596 | 220006840 | 1.75 | 12.4 | Curative (C) | 2013-10-12 | 2013-10-19 | BMT Fludarabine/Thiotepa/Treosulfan + ATG | N | N | 220026266 | NOT MATCHED |
| 220020597 | 220006845 | 1.68 | null | Disease modification (D) | 2017-07-30 | 2017-07-30 | null | null | null | 220026282 | NOT MATCHED |
| 220020598 | 220006861 | null | null | Palliative (P) | 2018-12-08 | 2018-12-08 | Hydroxycarbamide | N | N | 220026317 | HYDROXYCARBAMIDE |
| 220020599 | 220006867 | 1.57 | 13.8 | null | 2013-04-24 | 2013-07-07 | AML MyeChild 01 B Cytarabine/Daunoxome | N | N | 220026335 | NOT MATCHED |
| 220020600 | 220019598 | 1.52 | 73.1 | Disease modification (D) | 2016-11-26 | 2016-11-27 | AML Relapsed FLA - Idarubicin | 02 | N | 220026341 | NOT MATCHED |
| 220020601 | 220006875 | null | 63.4 | Disease modification (D) | 2013-11-28 | 2013-12-17 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220026358 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020602 | 220006878 | null | 55 | Curative (C) | 2018-03-09 | 2018-03-14 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220026364 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020603 | 220006881 | 1.66 | 0 | Curative (C) | 2017-09-12 | 2017-09-13 | Dasatinib | 2 | N | 220026371 | DASATINIB |
| 220020604 | 220006887 | 1.67 | null | Curative (C) | 2019-07-19 | 2019-07-25 | Dasatinib | null | N | 220026391 | DASATINIB |
| 220020605 | 220017513 | 1.61 | 70.4 | Curative (C) | 2017-01-29 | 2017-01-29 | AML 18 TRIAL | 01 | null | 220026415 | AML18 TRIAL |
| 220020606 | 220006892 | 1.65 | 86.2 | Curative (C) | 2015-02-26 | 2015-03-06 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220026416 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020607 | 220006899 | 1.58 | 62.4 | Curative (C) | 2013-05-27 | 2013-07-25 | AML 18 TRIAL | N | N | 220026461 | AML18 TRIAL |
| 220020608 | 220006912 | 1.7 | 93.15 | Curative (C) | 2013-06-30 | 2013-07-05 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220026504 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020609 | 220006919 | 1.76 | 84.2 | Curative (C) | 2016-11-20 | 2016-11-20 | AML18 PILOT TRIAL | 1 | N | 220026565 | PILOT TRIAL |
| 220020610 | 220006924 | null | 78 | Curative (C) | 2014-11-27 | 2014-11-27 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220026577 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020611 | 220013820 | 1.6 | 59 | Curative (C) | null | 2017-09-26 | AML 18 TRIAL | N | null | 220026587 | AML18 TRIAL |
| 220020612 | 220006938 | null | 83.3 | Disease modification (D) | 2017-11-01 | 2018-02-05 | AML18 PILOT TRIAL | N | null | 220026612 | PILOT TRIAL |
| 220020613 | 220006942 | 0 | 64.1 | Curative (C) | 2016-12-13 | 2016-12-13 | Dasatinib | 02 | N | 220026621 | DASATINIB |
| 220020614 | 220006949 | null | 58 | Palliative (P) | 2015-02-02 | 2015-02-02 | AML 18 TRIAL | 01 | N | 220026636 | AML18 TRIAL |
| 220020615 | 220006959 | 1.81 | 76.2 | Disease modification (D) | 2016-09-28 | 2016-09-29 | Rituximab | N | N | 220026681 | RITUXIMAB |
| 220020616 | 220006960 | 0 | 101.5 | Curative (C) | 2013-10-19 | 2013-11-06 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | N | 220026683 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020617 | 220006962 | 1.6 | 75.2 | Disease modification (D) | 2014-10-03 | 2014-10-03 | Rituximab | N | N | 220026693 | RITUXIMAB |
| 220020618 | 220021483 | null | 127 | Curative (C) | 2018-10-08 | 2018-10-08 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | N | 220026725 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020619 | 220022261 | 1.75 | 0 | Not known (9) | 2016-03-18 | 2016-03-18 | Dasatinib | 02 | N | 220026734 | DASATINIB |
| 220020622 | 220021484 | 1.67 | 92.3 | Curative (C) | 2016-07-16 | 2016-07-19 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | null | 220026840 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020623 | 220007009 | 1.68 | 71 | Curative (C) | 2017-11-22 | 2017-12-24 | AML 18 TRIAL | N | N | 220026878 | AML18 TRIAL |
| 220020625 | 220007026 | 1.73 | 84 | Curative (C) | 2017-06-13 | 2017-06-14 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220026928 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220020626 | 220007035 | 1.7 | null | Curative (C) | 2018-05-17 | 2018-05-17 | Alemtuz+Fludara+Melphalan RIC MUD | null | N | 220026961 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |